Galera Therapeutics Inc Says on May 31, Co Received Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined to Delist Co’s Shares
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.